Caffeine: Mechanism of Alertness and Cognitive Enhancement
Pharmacology
Caffeine (1,3,7-trimethylxanthine) is a non-selective adenosine receptor antagonist (A₁, A₂A).
Mechanism
- Adenosine accumulates during wakefulness → binds A₁/A₂A → inhibits acetylcholine, dopamine, norepinephrine release → sleep pressure.
- Caffeine blocks receptors → disinhibits arousal neurotransmitters.
- Secondary: ↑cAMP (PDE inhibition), ↑Ca²⁺ release, mild dopamine D2 affinity.
Effects
- Alertness, vigilance, reaction time (50–300 mg).
- Working memory, executive function (moderate dose).
- Mood elevation (low-moderate); anxiety/jitter (high dose/sensitive).
- Ergogenic: ↑time to exhaustion, ↓RPE.
Practical Limits
- Half-life 3–7 hrs (CYP1A2 polymorphism; smoking halves, OCP doubles).
- Ceiling effect ~400 mg/day; >600 mg → toxicity (tachycardia, insomnia, GI).
- Dependence: withdrawal headache, fatigue at 12–24h abstinence.
Chronic Fatigue Syndrome - Related Articles
- Boost Energy & Focus: Natural Strategies for Enhanced Mental Performance
- Tourette Syndrome: Genetic and Environmental Causes, Not Just Stress
- Understanding Fatigue: Causes, Symptoms, and When to Seek Help
- Caffeine: Mechanism of Alertness and Cognitive Enhancement
- Defensive Driving for Fatigue: 11 Strategies to Combat Drowsiness Behind the Wheel
- Narcolepsy vs. ME/CFS: Differential Diagnosis Guide for Clinicians and Patients
- Chronic Tiredness: Common Causes from Sleep Deprivation to Medical Conditions
